OVERALL SURVIVAL (OS) IN METASTATIC RENAL CELL CARCINOMA (MRCC) PATIENTS' SEQUENTIALLY TREATED WITH TARGETED THERAPIES (TTS)

被引：0
|
作者：
Procopio, G. [1 ]
Verzoni, E. [1 ]
Testa, I. [1 ]
de Braud, F. [1 ]
机构：
[1] Fdn IRCCS Ist Nazl Tumori, Milan, Italy
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：24 / 24
页数：1
相关论文
共 50 条
  • [21] Association between treatment effects on disease progression (DP) endpoints and overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC)
    Delea, T. E.
    Khuu, A.
    Kay, A.
    Zheng, J.
    Baladi, J. F.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (15)
  • [22] Prognostic ability of early tumor shrinkage on overall survival (OS) in metastatic renal cell carcinoma (mRCC) - a validation study
    Pond, G. R.
    Dietrich, M.
    Gruenwald, V.
    [J]. ANNALS OF ONCOLOGY, 2016, 27
  • [23] Progression-free survival (PFS) and overall survival (OS) across ethnicities for patients with metastatic renal cell carcinoma (mRCC) receiving targeted therapies (TT) as first-line (1L) treatment
    Salgia, Nicholas
    Dizman, Nazli
    Bergerot, Paulo Gustavo
    Bergerot, Cristiane Decat
    Hsu, Joann
    Pal, Sumanta K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (06)
  • [24] Progression-free survival (PFS) of first-line VEGF-targeted therapy as a prognostic parameter for overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC).
    Seidel, C.
    Fenner, M.
    Reuter, C. W.
    Ganser, A.
    Gruenwald, V.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [25] Nutritional screening is strongly associated with overall survival in patients treated with targeted agents for metastatic renal cell carcinoma
    Gu, Weijie
    Zhang, Guiming
    Sun, Lijiang
    Ma, Qi
    Cheng, Yue
    Zhang, Hailiang
    Shi, Guohai
    Zhu, Yao
    Ye, Dingwei
    [J]. JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE, 2015, 6 (03) : 222 - 230
  • [26] Time to surgery (TTS) in renal cell carcinoma (RCC): Predictors and association with overall survival (OS).
    Kommalapati, Anuhya
    Tella, Sri Harsha
    Tandra, Pavankumar
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [27] Impact of geographic region on overall survival (OS) in patients with metastatic renal cell carcinoma (mRCC): Results from a pooled clinical trials database
    Fay, Andre Poisl
    Mckay, Rana R.
    Lin, Xun
    Sinnantov, Ronit
    Choueiri, Toni K.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [28] A LONG-TERM SURVIVAL IN METASTATIC PAPILLARY RENAL CELL CARCINOMA TREATED WITH TARGETED THERAPIES
    Roberto, Michela
    Bassanelli, Maria
    Giacinti, Silvana
    Poti, Giulia
    Macrini, Serena
    Aschelter, Anna Maria
    Marchetti, Paolo
    [J]. ANTICANCER RESEARCH, 2017, 37 (04) : 2087 - 2088
  • [29] OVERALL SURVIVAL DATA WITH SEQUENTIAL TARGETED THERAPIES IN METASTATIC RENAL CELL CANCER
    Procopio, Giuseppe
    Verzoni, Elena
    Iacovelli, Roberto
    Guadalupi, Valentina
    Agustoni, Francesco
    Gelsomino, Francesco
    Colonna, Valentina
    Stagni, Silvia
    Salvioni, Roberto
    [J]. ANTICANCER RESEARCH, 2011, 31 (05) : 1831 - 1831
  • [30] Overall survival (OS) in renal cell carcinoma (RCC) before and after the introduction of targeted therapies (TTs): A Norwegian population-based study (2000-2011).
    Klepp, Olbjorn Harald
    Johannesen, Tom Borge
    Oldenburg, Jan
    Torgersen, Knut Martin
    Kowalski, Jan
    Solli, Oddvar
    Sandin, Rickard
    Beisland, Christian
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07)
12345